Norges Bank Replimune Group, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $2.3 Million - $4.35 Million	459,900 New	459,900 $4.14 Million
Q3 2023 Nov 13, 2023	SELL	$15.96 - $22.18 $1.46 Million - $2.03 Million	-91,300 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $1.43 Million - $2.2 Million	-91,300 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$17.48 - $29.09 $2.48 Million - $4.12 Million	141,700 New	141,700 $2.5 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $2.42 Million - $3.95 Million	141,700 New	141,700 $3.85 Million
Q3 2022 Nov 13, 2023	BUY	$15.6 - $21.15 $1.42 Million - $1.93 Million	91,300 New	91,300 $1.58 Million
Q2 2022 Aug 14, 2023	BUY	$13.32 - $19.98 $1.22 Million - $1.82 Million	91,300 New	91,300 $1.6 Million
Q1 2022 May 12, 2023	BUY	$15.24 - $29.75 $7.01 Million - $13.7 Million	459,745 Added 324.45%	601,445 $10.2 Million
Q1 2022 May 09, 2022	SELL	$15.24 - $29.75 $9.17 Million - $17.9 Million	-601,445 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$25.43 - $34.25 $15.3 Million - $20.6 Million	601,445 New	601,445 $16.3 Million
Q3 2021 Nov 14, 2022	BUY	$28.98 - $39.54 $17.4 Million - $23.8 Million	601,445 New	601,445 $17.8 Million
Q3 2021 Nov 05, 2021	SELL	$28.98 - $39.54 $17.4 Million - $23.8 Million	-601,445 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$28.5 - $39.37 $17.1 Million - $23.7 Million	601,445 New	601,445 $23.1 Million
Q2 2021 Aug 10, 2021	SELL	$28.5 - $39.37 $17.1 Million - $23.7 Million	-601,445 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$30.22 - $45.57 $18.2 Million - $27.4 Million	601,445 New	601,445 $18.4 Million
Q1 2021 May 07, 2021	SELL	$30.22 - $45.57 $22.7 Million - $34.3 Million	-751,806 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$23.5 - $52.65 $17.7 Million - $39.6 Million	751,806 New	751,806 $28.7 Million
Q4 2020 Feb 10, 2021	SELL	$23.5 - $52.65 $22.5 Million - $50.4 Million	-958,000 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$18.85 - $27.0 $18.1 Million - $25.9 Million	958,000 New	958,000 $22.1 Million
Q3 2020 Nov 10, 2020	SELL	$18.85 - $27.0 $17.1 Million - $24.4 Million	-904,700 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$9.76 - $25.95 $8.83 Million - $23.5 Million	904,700 New	904,700 $22.5 Million
Q2 2020 Aug 07, 2020	SELL	$9.76 - $25.95 $5.71 Million - $15.2 Million	-585,000 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$8.9 - $19.08 $5.21 Million - $11.2 Million	585,000 New	585,000 $5.83 Million
Q1 2020 May 08, 2020	SELL	$8.9 - $19.08 $5.21 Million - $11.2 Million	-585,000 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$11.61 - $17.21 $6.79 Million - $10.1 Million	585,000 New	585,000 $8.4 Million
Q4 2019 Feb 12, 2020	SELL	$11.61 - $17.21 $3.89 Million - $5.77 Million	-335,000 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$10.01 - $16.87 $3.35 Million - $5.65 Million	335,000 New	335,000 $4.66 Million
Q3 2019 Nov 08, 2019	SELL	$10.01 - $16.87 $3.35 Million - $5.65 Million	-335,000 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$12.51 - $17.28 $4.19 Million - $5.79 Million	335,000 New	335,000 $4.91 Million
Q2 2019 Aug 09, 2019	SELL	$12.51 - $17.28 $4.19 Million - $5.79 Million	-335,000 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$9.97 - $15.57 $3.34 Million - $5.22 Million	335,000 New	335,000 $3.35 Million
Q4 2018 Feb 08, 2019	SELL	$9.97 - $15.57 $3.34 Million - $5.22 Million	-335,000 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$14.99 - $22.14 $5.02 Million - $7.42 Million	335,000 New	335,000 $5.39 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

Baker Bros. Advisors LP New York, NY

11M
Shares

$156 Million
1.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

9.88M
Shares

$139 Million
0.01% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.87M
Shares

$68.5 Million
9.16% of portfolio
Redmile Group, LLC San Francisco, CA

4.78M
Shares

$67.3 Million
3.43% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$66.4 Million
0.0% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account